CA-QUANTA-CLOUD-TECH
6.4.2021 17:02:07 CEST | Business Wire | Press release
Quanta Cloud Technology (QCT), a global data center solution provider, announced its next-generation server systems supporting the 3rd Gen Intel Xeon Scalable processors featuring built-in AI and crypto acceleration which are optimized for the most popular AI frameworks to boost performance over their previous generation of processors.
With these new 3rd Gen Intel Xeon Scalable processors, formerly code-named Ice Lake, QCT has expanded its QuantaGrid and QuantaPlex server portfolio to fully support the new innovations that Intel pioneers for the most demanding workload requirements. Optimized for cloud enterprise, AI, HPC, network, and IoT workloads, 3rd Gen Intel Xeon Scalable processors achieves greater security with Intel Software Guard Extension (Intel SGX), Intel Total Memory Encryption (Intel TME), Intel Crypto Acceleration, and Intel Platform Firmware Resilience (Intel PFR) to enable enhanced collaboration using shared data without compromising privacy.
“We are strongly committed to providing our mutual customers with the latest data center technologies,” said Mike Yang, President of QCT. “To get businesses up and running with ready-to-adopt solutions we have expanded our portfolio with offerings that not only fully utilize Intel’s 3rd Gen Intel Xeon Scalable processors, but also include QCT’s own innovations and serviceability designs that reduce complexity while providing users with more flexibility when running their specialized workloads.”
“The latest 3rd Gen Intel Xeon Scalable platforms offer significantly more general compute performance, built-in AI acceleration and cryptography, and security capabilities that open up new ways for organizations to help protect their data and securely collaborate,” said Lisa Spelman, Corporate Vice President of Xeon and Memory Group at Intel. “These new platforms unleash new levels of flexible performance and security for our customers and cloud data center leaders like QCT.”
QCT systems incorporating the new core architecture can deliver up to 40 powerful cores per CPU, PCIe Gen4 support, and 8 DDR4 memory channels per socket supporting the Intel Optane persistent memory 200 series for increased memory, so customers can expect better data center performance for their workloads, while enabling enterprise cloud services such as video analytics and CDN.
QCT servers that support the 3rd Gen Intel Xeon Scalable processors:
- QuantaGrid D53X-1U - Balanced architecture with built-in acceleration and advanced security for hybrid cloud infrastructures, HCI, and data analytics.
- QuantaGrid D53XQ-2U - Optimized for AI acceleration and scalability with flexible NVMe support for HPC and enterprise workloads.
- QuantaPlex T43Z-2U - High density server optimized for extreme compute performance and space efficiency for a variety of workloads.
For more information on QCT and QCT products visit: http://go.qct.io/intel-icelake-processor-products/
About Quanta Cloud Technology (QCT)
QCT is a global data center solution provider that combines the efficiency of hyperscale hardware with infrastructure software from a diversity of industry leaders to solve next-generation data center design and operational challenges. QCT serves cloud service providers, telecoms and enterprises running public, hybrid and private clouds.
Product lines include hyperconverged and software-defined data center solutions as well as servers, storage, switches and integrated racks with an ecosystem of hardware components and software partners. QCT designs, manufactures, integrates and services its offerings via its own global network. The parent of QCT is Quanta Computer, Inc., a Fortune Global 500 corporation.
Intel, the Intel logo and other Intel marks are trademarks of Intel Corporation or its subsidiaries. Other names and brands may be claimed as the property of others.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210406005008/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership4.8.2026 11:00:00 CEST | Press release
The integration gives eligible WHOOP members seamless access to the only FDA-cleared hormone-free birth control app, with the first year of Natural Cycles° included for those new to the app as part of their WHOOP membership. WHOOP, the human performance company, today announced an expansion of its women’s health offering through an integration with Natural Cycles° (NC°), the only FDA-cleared, hormone-free birth control app. WHOOP is offering a 12-month subscription to the NC° app to eligible new Natural Cycles users. Members with compatible WHOOP devices can now automatically share overnight skin temperature with the NC° app to enable personalized fertility insights and hormone-free birth control. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260804399367/en/ WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership The Natural Cycles app, a Class II medical device, u
Alphatax Makes Two Acquisitions to Strengthen Transfer Pricing Capabilities4.8.2026 10:00:00 CEST | Press release
Acquisitions Expand Transfer Pricing Offering and Support Long-Term Platform Strategy Alphatax, the global tax compliance software provider, has today announced the acquisitions of TP Accurate and Intra Pricing Solutions, expanding its transfer pricing capabilities and reinforcing its ambition to build the world's first tax operating system. The acquisitions strengthen Alphatax's transfer pricing portfolio with complementary capabilities across financial transactions and documentation. TP Accurate provides specialist software for intra-group financing arrangements, while Intra Pricing Solutions' flagship product, TPGenie, enables multinational organisations and advisors to produce transfer pricing documentation using intelligent automation and AI. Together, they expand Alphatax's ability to support the full transfer pricing lifecycle, helping customers manage compliance more efficiently while improving governance and reducing audit risk. They also represent another step towards Alphata
LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care4.8.2026 09:10:00 CEST | Press release
LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and biopharmaceutical partners through LabPMM’s global laboratory network, with CAP/CLIA-accredited testing available in the U.S. The service addresses a growing need for accurate molecular monitoring in acute leukemias.1,2,3 KMT2A rearrangements (KMT2Ar) are oncogenic drivers in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).4 These rearrangements are present in about 80% of infant cases and 5-15% of childhood and adult leukemia cases.5 KMT2Ar leukemias are associated with chemotherapy resistance, high relapse rates, and poor clinical outcomes.5 The emergence of menin inhibitors is transforming the therapeutic landscape for patients with AML and ALL, particularly those with KMT2A-rearranged and NPM1-mutated disease.6 The
“HATSUNE MIKU LIGHTS TOKYO” Debuts on July 254.8.2026 09:00:00 CEST | Press release
Giant Hatsune Miku Returns to Light Up Tokyo’s Night! The Tokyo Metropolitan Government has been presenting year-round projection mapping displays on the Tokyo Metropolitan Government Building, using light and sound to showcase a wide range of artistic expressions as part of its efforts to create new nighttime tourism attractions in Tokyo. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260802298570/en/ © Crypton Future Media, INC. On Saturday, July 25, "HATSUNE MIKU LIGHTS TOKYO", featuring the globally beloved virtual singer Hatsune Miku, held its first screening. The work brings the world of the popular song “M@GICAL☆CURE! LOVE ♥ SHOT!” to life across the entire façade of the Tokyo Metropolitan Government Building. Since its launch in February 2024, “TOKYO Night & Light” has welcomed visitors from Japan and around the world, with total attendance surpassing 1.55 million. As one of Tokyo’s emerging landmark attractions, the
Mosaic Therapeutics appoints Dr Allison Jeynes as Chair of the Board4.8.2026 09:00:00 CEST | Press release
Accomplished life sciences leader with a proven track record of driving successful development of novel therapeutics, joins Mosaic to guide its next phase of growthAllison brings three decades of drug development, board and executive leadership experience to support Mosaic’s transition towards a clinical-stage company Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company developing novel, targeted drug combinations across a range of haematological and solid cancers, today announced the appointment of Dr Allison Jeynes as Chair of the Board to support its next phase of growth and advancement towards clinical development. Allison succeeds Dr Edward Hodgkin, who remains a Non-Executive Director of the Board. Allison is a UK-trained oncologist and highly-experienced life sciences leader, and brings over three decades of drug development and executive experience to Mosaic Therapeutics. As CEO of Avillion, a clinical development company, for the last 13 year
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom